NRC Health (NRC)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 133 | 148 | 152 | 149 | 143 | 137 | 140 | 118 |
| Operating profit | $m | 23 | 15 | ||||||
| Net profit | $m | 37 | 37 | 32 | 31 | 25 | 12 | 6 | 20 |
| EPS reported | $ | 0.52 | 0.25 | ||||||
| Operating cashflow per share | $ | 1.18 | 1.34 | ||||||
| Capex per share | $ | 0.48 | 0.36 | ||||||
| FCF per share | $ | 0.70 | 0.98 | ||||||
| Free cash flow | $m | 16 | 22 | ||||||
| Net debt | $m | 75 | 87 | ||||||
| Book value equity | $m | 14 | 7 | ||||||
| Book value per share | $ | 0.62 | 0.30 | ||||||
| Number of shares | m | 22.4 | 22.01 | ||||||
| DPS (TTM paid) | $ | 0.52 | 0.64 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 36.10 | 79.48 | ||||||
| P/B LTM | x | 30.03 | 64.15 | ||||||
| P/S LTM | x | 3.06 | 3.00 | ||||||
| P/FCF LTM | x | 26.69 | 19.41 | ||||||
| EV/EBITDA LTM | x | 16.38 | 21.14 | ||||||
| EV/Sales LTM | x | 3.60 | 4.03 | ||||||
| Earnings Yield LTM | % | +2.77% | +1.26% | ||||||
| FCF Yield | % | +3.75% | +5.15% | ||||||
| Quality | |||||||||
| ROE | % | +82.92% | +48.46% | ||||||
| ROIC | % | +14.36% | +8.75% | ||||||
| Operating margin | % | +16.44% | +10.53% | ||||||
| Gross margin | % | +56.33% | +66.79% | ||||||
| FCF/Sales | % | +11.46% | +15.46% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -50.00% | -75.96% | ||||||
| Sales Growth YoY | % | -3.96% | -2.14% | ||||||
| Net Income Growth YoY | % | -53.19% | -76.37% | ||||||
| FCF Growth | % | -17.90% | +12.85% | ||||||
| Operating Profit Growth | % | -35.81% | -58.13% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +2.61% | +2.83% | ||||||
| Dividend Growth | % | +8.33% | +33.33% | ||||||
| Payout Ratio | % | +94.26% | +227.98% | ||||||
| FCF/Debt | x | 0.20 | 0.24 | ||||||
| Net Debt/EBITDA | x | 2.48 | 3.70 | ||||||
| EBIT/Net interest | x | 4.74 | 2.73 | ||||||
| Net debt/market cap | % | +18.81% | +18.85% | ||||||
| Net debt/Equity | x | 5.35 | 13.24 | ||||||
| Gross debt/equity | x | 5.65 | 13.75 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free